POPULATION PHARMACOKINETICS OF CEFPODOXIME IN BOTTLENOSE DOLPHINS (TURSIOPS TRUNCATUS)
Journal of Zoo and Wildlife Medicine · 2024
DOI: 10.1638/2023-0139 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Zoo and Wildlife Medicine, 2024. Verfasst von Barbara K Linnehan und 8 weiteren Autor:innen. Beteiligte Einrichtung: National Marine Mammal Foundation, San Diego, CA 92106, USA, barb.linnehan@nmmf.org. Hauptthemen laut MEDLINE: Bottle-Nosed Dolphin, Anti-Bacterial Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
Cefpodoxime proxetil is commonly used to treat cetacean patients with suspected or confirmed bacterial infections; however, pharmacokinetic data are needed to guide proper dosing in these species. Cefpodoxime proxetil is a time-dependent, semisynthetic, third-generation cephalosporin, appropriate for once-daily dosing and U.S. Food and Drug Administration–approved for use in dogs with a broad spectrum of activity including gram-positive and gram-negative species. The objective of this study was to evaluate the population pharmacokinetics of cefpodoxime in bottlenose dolphins (Tursiops truncatus). A sparse-sampling design was used, with serum from dolphins receiving cefpodoxime proxetil at 10 mg/kg orally every 24 h to treat suspected or confirmed bacterial infections. Serum samples (n = 57) from 24 dolphins were analyzed at 12 time points from 0 to 96 h postdose. Serum samples were analyzed using liquid chromatography–mass spectrometry. Population pharmacokinetic analysis was performed using nonlinear mixed-effects modeling. One- and two-compartment linear models with first order absorption were tested. Covariates including weight, age, and sex were considered for inclusion in the model, and between-subject variability was incorporated. A two-compartment model performed best, where following an oral dose of 10 mg/kg, serum concentration reached a mean maximum concentration of 23.0 µg/ml, mean time to maximum concentration of 5.0 h, and mean half-life of 11.4 h. With daily dosing, accumulation was approximately 18% and steady state was reached by the second dose. Serum protein binding was 82.8% as determined by equilibrium dialysis, similar to plasma protein binding reported in dogs. Based on the population pharmacokinetic model, once-daily oral dosing was systemically absorbed and quickly reached maximum concentrations. The half-life in dolphins appears to be longer than other species studied to date. Given the paucity of antimicrobial pharmacokinetic studies in dolphins, and limited once-daily oral antibiotic options for this species, these data are helpful for clinicians to make informed antimicrobial choices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- National Marine Mammal Foundation, San Diego, CA 92106, USA, barb.linnehan@nmmf.org.
- Veterinary Medicine Research and Development, Zoetis Inc., Kalamazoo, MI 49007, USA.
- National Marine Mammal Foundation, San Diego, CA 92106, USA.
- U.S. Navy Marine Mammal Program, Naval Information Warfare Center Pacific, San Diego, CA 92106, USA.
Zitieren
APA
Linnehan, B. K., Lesman, S. P., Boucher, J. F., Grover, G. S., Brodie, E. C., Meegan, J. M., McClain, A. M., Ross, K. P., & Jensen, E. D. (2024). POPULATION PHARMACOKINETICS OF CEFPODOXIME IN BOTTLENOSE DOLPHINS (TURSIOPS TRUNCATUS). Journal of Zoo and Wildlife Medicine. https://doi.org/10.1638/2023-0139
Vancouver
Linnehan BK, Lesman SP, Boucher JF, Grover GS, Brodie EC, Meegan JM, et al. POPULATION PHARMACOKINETICS OF CEFPODOXIME IN BOTTLENOSE DOLPHINS (TURSIOPS TRUNCATUS). Journal of Zoo and Wildlife Medicine. 2024. doi:10.1638/2023-0139
BibTeX
@article{Linnehan2024,
author = {Linnehan, Barbara K and Lesman, Steven P and Boucher, Joseph F and Grover, G Scott and Brodie, Erin C and Meegan, Jennifer M and McClain, Abby M and Ross, Kyle P and Jensen, Eric D},
title = {POPULATION PHARMACOKINETICS OF CEFPODOXIME IN BOTTLENOSE DOLPHINS (TURSIOPS TRUNCATUS)},
journal = {Journal of Zoo and Wildlife Medicine},
year = {2024},
doi = {10.1638/2023-0139}
}
EUVIMED